Search alternatives:
nn decrease » _ decrease (Expand Search), gy decreased (Expand Search), b1 decreased (Expand Search)
we decrease » _ decrease (Expand Search), teer decrease (Expand Search), use decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
nn decrease » _ decrease (Expand Search), gy decreased (Expand Search), b1 decreased (Expand Search)
we decrease » _ decrease (Expand Search), teer decrease (Expand Search), use decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
5441
-
5442
Seven-day moving average number of PHC visits and health events during 2020.
Published 2025Subjects: -
5443
-
5444
-
5445
-
5446
-
5447
-
5448
Layer-Thickness-Dependent Strengthening–Toughening Mechanisms in Crystalline/Amorphous Nanolaminates
Published 2025“…Here, we employ large-scale molecular dynamics simulations to investigate the compressive deformation of C/A nanopillars composed of alternating equal-thickness crystalline Cu and amorphous Cu<sub>50</sub>Zr<sub>50</sub> layers. …”
-
5449
Layer-Thickness-Dependent Strengthening–Toughening Mechanisms in Crystalline/Amorphous Nanolaminates
Published 2025“…Here, we employ large-scale molecular dynamics simulations to investigate the compressive deformation of C/A nanopillars composed of alternating equal-thickness crystalline Cu and amorphous Cu<sub>50</sub>Zr<sub>50</sub> layers. …”
-
5450
Layer-Thickness-Dependent Strengthening–Toughening Mechanisms in Crystalline/Amorphous Nanolaminates
Published 2025“…Here, we employ large-scale molecular dynamics simulations to investigate the compressive deformation of C/A nanopillars composed of alternating equal-thickness crystalline Cu and amorphous Cu<sub>50</sub>Zr<sub>50</sub> layers. …”
-
5451
Layer-Thickness-Dependent Strengthening–Toughening Mechanisms in Crystalline/Amorphous Nanolaminates
Published 2025“…Here, we employ large-scale molecular dynamics simulations to investigate the compressive deformation of C/A nanopillars composed of alternating equal-thickness crystalline Cu and amorphous Cu<sub>50</sub>Zr<sub>50</sub> layers. …”
-
5452
Layer-Thickness-Dependent Strengthening–Toughening Mechanisms in Crystalline/Amorphous Nanolaminates
Published 2025“…Here, we employ large-scale molecular dynamics simulations to investigate the compressive deformation of C/A nanopillars composed of alternating equal-thickness crystalline Cu and amorphous Cu<sub>50</sub>Zr<sub>50</sub> layers. …”
-
5453
Layer-Thickness-Dependent Strengthening–Toughening Mechanisms in Crystalline/Amorphous Nanolaminates
Published 2025“…Here, we employ large-scale molecular dynamics simulations to investigate the compressive deformation of C/A nanopillars composed of alternating equal-thickness crystalline Cu and amorphous Cu<sub>50</sub>Zr<sub>50</sub> layers. …”
-
5454
Overall analysis of randomized controlled trials.
Published 2025“…Collectively, statins significantly reduced IL-6 (<i>MD = -0.24</i> ng/dL <i>[95% CI, -0.36 to -0.13], I</i><sup><i>2</i></sup> <i>= 98.3%, p < 0.001</i>), TNF-α (<i>MD = -0.74</i> ng/dL <i>[95% CI, -1.08 to -0.40], I</i><sup><i>2</i></sup> <i>= 98.8%, p < 0.001</i>); and CRP (<i>MD = -1.58</i> mg/L <i>[95% CI, -2.22 to -0.94], I</i><sup><i>2</i></sup> <i>= 86.5%, p < 0.001</i>). Notably, atorvastatin demonstrated the most significant reduction in IL-6 and TNF-α levels, while fluvastatin and rosuvastatin displayed the greatest impact on decreasing CRP and LDL-C levels, respectively. …”
-
5455
Newcastle-Ottawa scale.
Published 2025“…Collectively, statins significantly reduced IL-6 (<i>MD = -0.24</i> ng/dL <i>[95% CI, -0.36 to -0.13], I</i><sup><i>2</i></sup> <i>= 98.3%, p < 0.001</i>), TNF-α (<i>MD = -0.74</i> ng/dL <i>[95% CI, -1.08 to -0.40], I</i><sup><i>2</i></sup> <i>= 98.8%, p < 0.001</i>); and CRP (<i>MD = -1.58</i> mg/L <i>[95% CI, -2.22 to -0.94], I</i><sup><i>2</i></sup> <i>= 86.5%, p < 0.001</i>). Notably, atorvastatin demonstrated the most significant reduction in IL-6 and TNF-α levels, while fluvastatin and rosuvastatin displayed the greatest impact on decreasing CRP and LDL-C levels, respectively. …”
-
5456
-
5457
-
5458
-
5459
-
5460